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We report the first case of human melioidosis from
Mauritius, where Burkholderia pseudomallei has never
been isolated. The patient was immunocompromised, had
never traveled abroad, and had a history of regular expo-
sure to mud. She became ill at a time when rainfall was
higher than the monthly average. 
Melioidosis is an infectious disease of humans and ani-mals caused by Burkholderia pseudomallei (1).
Most documented cases occur in Southeast Asia and north-
ern Australia (2). In recent years, melioidosis has increas-
ingly been recognized in the Indian subcontinent (3). Only
a few cases have been reported in South America (4) and
Africa (5). In the islands of the southwest Indian Ocean,
although no human cases have been reported, B. pseudo-
mallei has been isolated from pigs in Madagascar as far
back as 1936 (6) and from the soil in Madagascar and La
Reunion (7). We report the first case of human melioidosis
in the southwest Indian Ocean island of Mauritius, where
B. pseudomallei has not been isolated previously. 
The Case
A 40-year-old patient was admitted to the hospital on
January 29, 2004, with fever, generalized weakness, diar-
rhea, and vomiting. Her temperature on admission was
39.2°C. Results of physical examination were unremark-
able. Initial blood tests showed hemoglobin level of 8.5
g/dL, leukocyte count of 4.9 x 109/L, and platelet count of
110 x 109/L. Erythrocyte sedimentation rate was elevated
at 88 mm/h. Her serum glucose level was 8.5 mmol/L, and
urea and electrolyte values were normal. She was started
on intravenous ciprofloxacin, but her fever persisted, and
she became increasingly confused. Two days after admis-
sion, therapy was changed to cefotaxime and metronida-
zole. A blood culture was collected the next day. The
following day, she had cellulitis of the right leg. She
remained feverish and intermittently drowsy and confused.
She died 9 days after being admitted. Her old hospital
records became available shortly after her death, and we
noted that she had been diagnosed with systemic lupus ery-
thematosus (SLE) in 1994. When she last attended the out-
patient department 3 months before her hospital
admission, she was prescribed 50 mg azathioprine and 5
mg prednisolone daily. She was a housewife and lived in
Cité La Cure, a poor suburb of the capital city Port-Louis.
She had never traveled abroad. According to her mother,
her home becomes very muddy after heavy rainfall, and
her feet were often in mud while performing her household
duties. 
After 5 days of incubation, an oxidase-positive, gram-
negative bacillus was isolated from blood cultures. It pro-
duced colonies that appeared dry and rugose on the plates
after 48 h and was identified as B. pseudomallei by using
API 20NE (BioMérieux, Marcy l’Etoile, France) with the
profile 1156577. Antimicrobial susceptibility testing by
disc diffusion showed the organism to be resistant to col-
istin, ampicillin, cephalexin, gentamicin, and ciprofloxacin
and susceptible to co-amoxiclav, tetracycline, cefotaxime,
ceftriaxone, ceftazidime, piperacillin, and meropenem. A
large zone of inhibition was seen around the co-trimoxa-
zole disc, within which a thin film of growth was observed.
Conclusions
This case represents the first time B. pseudomallei was
isolated in Mauritius. The patient must have been infected
in Mauritius because she never traveled abroad. We are not
aware of any study looking for the organism in soil in this
country. Veterinary cases do not appear to have been report-
ed previously in Mauritius (V.B. Groodoyal, pers. comm.).
Whether human cases of melioidosis have been missed in
the past is not known, and cases may be missed currently.
Recognizing the disease depends on awareness on the part
of clinicians and on the ability of microbiology laboratories
to identify the causative organism (1,8). Before 1998, oxi-
dase-positive, gram-negative bacilli other than P. aerugi-
nosa were not identified to species level in laboratories in
Mauritius. Since then, at our laboratory, which receives
specimens for bacteriologic investigations from all govern-
ment healthcare institutions, such organisms are routinely
identified by API 20NE when isolated in pure culture from
blood, but only occasionally when isolated from nonsterile
sites such as sputum and pus swabs. Thus, nonsepticemic
cases of melioidosis in Mauritius could easily have been
missed. Diagnosis also depends on appropriate specimens
being sent to the laboratory. Some clinicians routinely
request blood cultures from patients with high fever before
starting antimicrobial drugs, although in practice, the spec-
imen is often collected by nursing staff after the first dose
has already been administered. Other clinicians only
request blood cultures if fever persists after a few days of
empiric antimicrobial therapy. In the case reported here,
prior administration of cefotaxime may have delayed B.
pseudomallei culture from blood until 5 days of incubation,
when the median time to obtain a positive blood culture
result is typically 48 hours (1).
An association between rainfall and melioidosis has
long been recognized; most cases in Thailand (9) and
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northern Australia (10) occur during the wet season. The
increased number of cases noted during the rainy season
may be caused by the movement of B. pseudomallei from
deeper layers toward the surface when dry topsoil is mois-
tened by rainfall (2).
In Mauritius, the rainy season is December to March. In
January 2004, 196 mm rainfall was recorded in Port-Louis,
which is 37% higher than the 1971–2000 mean rainfall for
the region during this month. January 2004 was the sixth
wettest January of the past 30 years in Port-Louis.
Similarly above-average rainfall was recorded throughout
the island in 2004. 
Recent reviews have suggested a predominant role for
percutaneous B. pseudomallei infection in the pathogene-
sis of melioidosis (11). Studies carried out in regions
where melioidosis is endemic have shown that exposure to
wet soil and water are associated with increased risk for
disease (9). The feet of our patient were regularly exposed
to wet soil during rainy periods.
In melioidosis-endemic areas, although a large percent-
age of the population has been exposed to B. pseudomallei,
as determined by seroprevalence studies, only a few devel-
op melioidosis (12). Most cases occur in patients with
underlying illnesses, such as diabetes mellitus, renal dis-
ease, and alcoholism (9,10) or in those who are immuno-
suppressed (1). Our patient had SLE and was on
immunosuppressive drugs. Septicemic melioidosis has
been reported in patients who have SLE (13). 
This first case of melioidosis in Mauritius occurred in
an immunosuppressed patient who had a history of pro-
longed and regular exposure to mud during a year when
rainfall was higher than average. This combination of 3
risk factors does not occur regularly, and it is possible that
few additional cases will be recorded in Mauritius in the
future. However, clinicians and laboratory staff must
remain aware of this disease, particularly because in a non-
communicable disease survey carried out in 1998, almost
20% of the Mauritian population >20 years of age were
found to have type 2 diabetes mellitus (14), the most com-
mon predisposing condition for melioidosis (1).
Determining the distribution of B. pseudomallei in soil in
Mauritius by conducting environmental investigations will
also be useful.
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